Tuberous sclerosis complex-mediated mTORC1 overactivation promotes age-related hearing loss

被引:56
|
作者
Fu, Xiaolong [1 ,2 ]
Sun, Xiaoyang [1 ,2 ]
Zhang, Linqing [1 ,2 ]
Jin, Yecheng [1 ,2 ]
Chai, Renjie [3 ]
Yang, Lili [1 ,2 ]
Zhang, Aizhen [1 ,2 ,4 ]
Liu, Xiangguo [1 ,2 ]
Bai, Xiaochun [5 ]
Li, Jianfeng [4 ]
Wang, Haibo [4 ]
Gao, Jiangang [1 ,2 ]
机构
[1] Shandong Univ, Sch Life Sci, 27 Shanda Nanlu, Jinan 250100, Shandong, Peoples R China
[2] Shandong Univ, Minist Educ Expt Teratol, Key Lab, Jinan, Shandong, Peoples R China
[3] Southeast Univ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China
[4] Shandong Univ, Prov Hosp, Dept Otolaryngol Head & Neck Surg, Jinan 250117, Shandong, Peoples R China
[5] Southern Med Univ, Sch Basic Med Sci, Dept Cell Biol, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China
来源
JOURNAL OF CLINICAL INVESTIGATION | 2018年 / 128卷 / 11期
关键词
AGING INNER-EAR; OXIDATIVE STRESS; HAIR-CELLS; INDUCED OTOTOXICITY; C57BL/6J MICE; LIFE-SPAN; IN-VIVO; ACTIVATION; RESTRICTION; DISEASE;
D O I
10.1172/JCI98058
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The underlying molecular mechanisms of age-related hearing loss (ARHL) in humans and many strains of mice have not been fully characterized. This common age-related disorder is assumed to be closely associated with oxidative stress. Here, we demonstrate that mTORC1 signaling is highly and specifically activated in the cochlear neurosensory epithelium (NSE) in aging mice, and rapamycin injection prevents ARHL. To further examine the specific role of mTORC1 signaling in ARHL, we generated murine models with NSE-specific deletions of Raptor or Tsc1, regulators of mTORC1 signaling. Raptor-cKO mice developed hearing loss considerably more slowly than WT littermates. Conversely, Tsc1 loss led to the early-onset death of cochlear hair cells and consequently accelerated hearing loss. Tsc1-cKO cochleae showed features of oxidative stress and impaired antioxidant defenses. Treatment with rapamycin and the antioxidant N-acetylcysteine rescued Tsc1-cKO hair cells from injury in vivo. In addition, we identified the peroxisome as the initial signaling organelle involved in the regulation of mTORC1 signaling in cochlear hair cells. In summary, our findings identify overactive mTORC1 signaling as one of the critical causes of ARHL and suggest that reduction of mTORC1 activity in cochlear hair cells may be a potential strategy to prevent ARHL.
引用
收藏
页码:4938 / 4955
页数:18
相关论文
共 50 条
  • [1] Persistent mTORC1 activation due to loss of liver tuberous sclerosis complex 1 promotes liver injury in alcoholic hepatitis
    Chao, Xiaojuan
    Wang, Shaogui
    Ma, Xiaowen
    Zhang, Chen
    Qian, Hui
    Williams, Sha Neisha
    Sun, Zhaoli
    Peng, Zheyun
    Liu, Wanqing
    Li, Feng
    Sheshadri, Namratha
    Zong, Wei-Xing
    Ni, Hong-Min
    Ding, Wen-Xing
    HEPATOLOGY, 2023, 78 (02) : 503 - 517
  • [2] mTORC1 Activity in Psoriatic Lesions Is Mediated by Aberrant Regulation through the Tuberous Sclerosis Complex
    Ferreri, Antonio
    Lang, Victoria
    Kaufmann, Roland
    Buerger, Claudia
    CELLS, 2022, 11 (18)
  • [3] mTORC1 activity in psoriatic lesions is mediated by aberrant regulation through the tuberous sclerosis complex (TSC)
    Lang, V.
    Ferreri, A.
    Diehl, S.
    Kaufmann, R.
    Buerger, C.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 (03) : E11 - E11
  • [4] mTORC1 activity in psoriatic lesions is mediated by aberrant regulation through the tuberous sclerosis complex (TSC)
    Ferreri, A.
    Lang, V.
    Diehl, S.
    Kaufmann, R.
    Buerger, C.
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (04) : E17 - E18
  • [5] Development of harmatomas is associated with constitutive activated mTORC1 in Tuberous Sclerosis complex
    Moeller, L. B.
    Schonewolf-Greulich, B.
    Rosengren, T.
    Larsen, L.
    Ostergaard, J.
    Sommerlund, M.
    Ostenfeldt, C.
    Stausbol-Gron, B.
    Linnet, K. Markussen
    Gregersen, P. Axel
    Jensen, U.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 621 - 621
  • [6] TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex
    Alesi, Nicola
    Khabibullin, Damir
    Rosenthal, Dean M.
    Akl, Elie W.
    Cory, Pieter M.
    Alchoueiry, Michel
    Salem, Samer
    Daou, Melissa
    Gibbons, William F.
    Chen, Jennifer A.
    Zhang, Long
    Filippakis, Harilaos
    Graciotti, Laura
    Miceli, Caterina
    Monfregola, Jlenia
    Vilardo, Claudia
    Morroni, Manrico
    Di Malta, Chiara
    Napolitano, Gennaro
    Ballabio, Andrea
    Henske, Elizabeth P.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [7] Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation
    Cao, Juxiang
    Tyburczy, Magdalena E.
    Moss, Joel
    Darling, Thomas N.
    Widlund, Hans R.
    Kwiatkowski, David J.
    JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (01): : 349 - 364
  • [8] TFEB drives mTORC1 hyperactivation and kidney disease in Tuberous Sclerosis Complex
    Nicola Alesi
    Damir Khabibullin
    Dean M. Rosenthal
    Elie W. Akl
    Pieter M. Cory
    Michel Alchoueiry
    Samer Salem
    Melissa Daou
    William F. Gibbons
    Jennifer A. Chen
    Long Zhang
    Harilaos Filippakis
    Laura Graciotti
    Caterina Miceli
    Jlenia Monfregola
    Claudia Vilardo
    Manrico Morroni
    Chiara Di Malta
    Gennaro Napolitano
    Andrea Ballabio
    Elizabeth P. Henske
    Nature Communications, 15
  • [9] Activation of Rheb, but not of mTORC1, impairs spine synapse morphogenesis in tuberous sclerosis complex
    Yasuda, Shin
    Sugiura, Hiroko
    Katsurabayashi, Shutaro
    Shimada, Tadayuki
    Tanaka, Hidekazu
    Takasaki, Kotaro
    Iwasaki, Katsunori
    Kobayashi, Toshiyuki
    Hino, Okio
    Yamagata, Kanato
    SCIENTIFIC REPORTS, 2014, 4
  • [10] Aberrant destabilization of the tuberous sclerosis complex (TSC) controls mTORC1 activity in psoriasis
    Lang, V.
    Ferreri, A.
    Diehl, S.
    Kaufmann, R.
    Buerger, C.
    EXPERIMENTAL DERMATOLOGY, 2022, 31 (02) : E16 - E16